Literature DB >> 18528942

Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement.

Xin-Bao Wang1, Li-Tao Yang, Ze-Wei Zhang, Jian-Min Guo, Xiang-Dong Cheng.   

Abstract

AIM: To characterize the factors of the improved survival following combined pancreaticoduodenectomy (PD) and gastrectomy for the treatment of advanced gastric cancer with pancreaticoduodenal region involvement.
METHODS: From 1995 to 2004, 53 patients with primary gastric cancer were diagnosed with synchronous (n = 44) or metachronous (n = 9) pancreaticoduodenal region involvement. Of these, 17 patients (32%) underwent total gastrectomy (TG) or distal subtotal gastrectomy (SG) combined with PD simultaneously. The preoperative demographic, clinical information, clinicopathologic features and the surgical results of these 17 patients were considered as factors influencing survival and were analyzed by the Kaplan-Meier method with log-rank comparison.
RESULTS: The actual 1- and 3-year survival rates of these 17 patients after resection were 77% and 34%, respectively, and three patients survived for more than 5 years after surgery. The tumor-free resection margin (P = 0.0174) and a well-differentiated histologic type (P = 0.0011) were significant prognostic factors on univariate analysis. No mortality occurred within one mo after operation, postoperative weight loss of different degree was present in all the patients with TG and 12 cases had other complications. There were 9 (53%) cases of recurrence in 5-48 mo after operation. The survival rate in the palliative and explorative group was significantly (P = 0.0064) lower than in the combined PD group.
CONCLUSION: Judicious use of en bloc PD and gastrectomy and strictly preventing postoperative complications may improve the long-term survival for advanced gastric cancer patients with pancreaticoduodenal region involvement. Well-differentiated histology and negative resection margin are the most important predictors of long survival.

Entities:  

Mesh:

Year:  2008        PMID: 18528942      PMCID: PMC2716599          DOI: 10.3748/wjg.14.3425

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Hepatic resection for metastatic tumors from gastric cancer.

Authors:  Keiichi Okano; Takashi Maeba; Ken Ishimura; Yukihiko Karasawa; Fuminori Goda; Hisao Wakabayashi; Hisashi Usuki; Hajime Maeta
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Results of resection of gastric cancer extending to adjacent organs.

Authors:  D Korenaga; T Okamura; H Baba; A Saito; K Sugimachi
Journal:  Br J Surg       Date:  1988-01       Impact factor: 6.939

3.  New developments in the treatment of gastric carcinoma.

Authors:  H Wilke; P Preusser; U Fink; W Achterrath; H J Mayer; M Stahl; L Lenaz; J Meyer; J R Siewert; H Gerlings
Journal:  Cancer Treat Res       Date:  1991

4.  Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach.

Authors:  Y Yonemura; S Ooyama; H Matumoto; T Kamata; H Kimura; S Takegawa; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Int Surg       Date:  1991 Oct-Dec

5.  Results of combined resection of invaded organs in patients with potentially curable, advanced gastric cancer.

Authors:  K Iriyama; T Ohsawa; T Tsuchibashi; M Noji; C Miki; K Ilunga; H Suzuki
Journal:  Eur J Surg       Date:  1994-01

6.  Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer.

Authors:  K Takeuchi; Y Tsuzuki; T Ando; M Sekihara; T Hara; M Yoshikawa; Y Ohno; H Kuwano
Journal:  J Surg Res       Date:  2001-12       Impact factor: 2.192

7.  Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.

Authors:  Henning Schulze-Bergkamen; Ivan Zuna; Andreas Teufel; Wolfgang Stremmel; Jochen Rudi
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

8.  Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

9.  Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma.

Authors:  P Piso; T Bellin; H Aselmann; H Bektas; H J Schlitt; J Klempnauer
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

10.  Complete ten-year postgastrectomy follow-up of early gastric cancer.

Authors:  H Itoh; Y Oohata; K Nakamura; T Nagata; R Mibu; F Nakayama
Journal:  Am J Surg       Date:  1989-07       Impact factor: 2.565

View more
  5 in total

1.  A case of multiorgan resection for locally advanced stomach cancer.

Authors:  Tevfik Küçükkartallar; Ebubekir Gündeş; Hüseyin Yılmaz; Faruk Aksoy
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

Review 2.  Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer.

Authors:  Patrick Roberts; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-08-26       Impact factor: 7.370

Review 3.  Gastric cancer: surgery in 2011.

Authors:  Katja Ott; Florian Lordick; Susanne Blank; Markus Büchler
Journal:  Langenbecks Arch Surg       Date:  2011-01-14       Impact factor: 3.445

4.  Laparoscopic Whipple's Operation for Locally Advanced Gastric Cancer Invading the Pancreas and Duodenum: a Case Report.

Authors:  Chang Min Lee; Sam-Youl Yoon; Sungsoo Park; Seong-Heum Park
Journal:  J Gastric Cancer       Date:  2019-08-01       Impact factor: 3.720

5.  Pancreaticoduodenectomy after neoadjuvant chemotherapy for gastric cancer invading the pancreatic head: A case report.

Authors:  Masahiro Yura; Kiminori Takano; Kiyohiko Adachi; Asuka Hara; Keita Hayashi; Yuki Tajima; Yasushi Kaneko; Yoichiro Ikoma; Hiroto Fujisaki; Akira Hirata; Kumiko Hongo; Kikuo Yo; Kimiyasu Yoneyama; Reiko Dehari; Kazuo Koyanagi; Motohito Nakagawa
Journal:  World J Gastroenterol       Date:  2021-02-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.